-
Published 4/22/2025
Kashyap VS, Beckman JA, Doros G, Menard MT, Rosenfield K, Creager MA, Tuttle KR, McGinigle KL, Huber T, Kinlay S, Drooz AT, Strong MB, Weinberg I, Farber A, Jaff MR. Optimal Medical Therapy Is Associated With Improved Limb Outcomes in PAD Patients: A BEST-CLI Substudy. J Am Coll Cardiol. 2025 Apr 22; 85(15):1568-1572. PMID: 40240095.
-
Published 3/1/2025
Moinul S, Urina-Jassir M, Rodriguez-Taveras J, Peralta AO, Hoffmeister PS, Kinlay S, Yarmohammadi H, Boden WE, Joseph J, Yuyun MF. Meta-Analysis of Racial and Ethnic Disparities in Rhythm Control Strategies for Atrial Fibrillation in the United States. Am J Cardiol. 2025 Jun 15; 245:1-10. PMID: 40032171.
-
Published 2/10/2025
Evans P, Sobieszczyk P, Eisenhauer AC, Todoran TM, Kinlay S. Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study. Catheter Cardiovasc Interv. 2025 Apr; 105(5):1214-1221. PMID: 39925321.
-
Published 1/21/2025
Hashem C, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Yuyun MF. Atrial Fibrillation Recurrence Post-Ablation Across Heart Failure Categories: A Systematic Review and Meta-analysis. Cardiol Res. 2025 Feb; 16(1):33-43. PMID: 39897444.
-
Published 12/29/2024
Khambhati J, Sobieszczyk P, Eisenhauer AC, Todoran TM, Kinlay S. Long-term risk of adverse limb outcomes in older patients after endovascular femoral artery revascularization: The Boston femoral artery endovascular revascularization outcomes (Boston FAROUT) study. Cardiovasc Revasc Med. 2024 Dec 29. PMID: 39779402.